On a side note, didn't MNTA do some minor trials for mLovenox, which we never heard about until after approval?
They did do some clinical immunogenicity trails. These trials as I recall are the basis for the SNY lawsuit against the FDA stating that the j pathway doesn't allow for trials showing safety/efficacy. The FDA counters that the immunogenicity trials were for assessing manufacturing purity.
Market Data 
Markets 
AI
